(Q34922070)

5 August 2017

title

In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

5 August 2017

main subject

0 references

author name string

A M Upton

1

1 reference

5 August 2017

S Cho

2

1 reference

5 August 2017

T J Yang

3

1 reference

5 August 2017

Y Kim

4

1 reference

5 August 2017

Y Wang

5

1 reference

5 August 2017

Y Lu

6

1 reference

5 August 2017

B Wang

7

1 reference

5 August 2017

J Xu

8

1 reference

5 August 2017

K Mdluli

9

1 reference

5 August 2017

Z Ma

10

1 reference

5 August 2017

S G Franzblau

11

1 reference

5 August 2017

language of work or name

English

0 references

publication date

20 October 2014

1 reference

Antimicrobial Agents and Chemotherapy

5 August 2017

published in

1 reference

5 August 2017

volume

59

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

136-144

1 reference

Contribution of the nitroimidazoles PA-824 and TBA-354 to the activity of novel regimens in murine models of tuberculosis

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

TMC207 becomes bedaquiline, a new anti-TB drug

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimen

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

PA-824 , moxifloxacin and pyrazinamide combination therapy for tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

A novel F(420) -dependent anti-oxidant mechanism protects Mycobacterium tuberculosis against oxidative stress and bactericidal agents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Delamanid for multidrug-resistant pulmonary tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Phase II dose-ranging trial of the early bactericidal activity of PA-824

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Nitroimidazoles for the treatment of TB: past, present and future

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

PA-824 exhibits time-dependent activity in a murine model of tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Dry powder PA-824 aerosols for treatment of tuberculosis in guinea pigs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

The mechanism of action of PA-824: Novel insights from transcriptional profiling

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Statistics in practice. Comparing the means of several groups.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4291341

Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1128%2FAAC.03823-14

Synthesis and Structure−Activity Relationships of Aza- and Diazabiphenyl Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1128%2FAAC.03823-14

Treatment of Trichomoniasis with Metronidazole

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25331696

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dose-ranging activity of the newly registered antituberculosis drug bedaquiline (TMC207)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25331696

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25331696

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.03823-14

1 reference

5 August 2017

1 reference

5 August 2017

1 reference